Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.4548
-0.0152 (-3.23%)
Oct 14, 2026, 3:37 PM EDT - Market open

Caribou Biosciences Revenue

Caribou Biosciences had revenue of $1.50M in the quarter ending June 30, 2026, a decrease of -43.79%. This brings the company's revenue in the last twelve months to $10.04M, up 10.02% year-over-year. In the year 2025, Caribou Biosciences had annual revenue of $11.16M with 11.66% growth. That makes Caribou Biosciences the 37,309th largest company in the world by revenue and 4,896th in the United States.

Revenue (ttm)
$10.04M
Revenue Growth
+10.02%
P/S Ratio
5.02
Revenue / Employee
$103,454
Employees
97
Market Cap
48.76M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202511.16M1.17M11.66%
Dec 31, 20249.99M-24.48M-71.01%
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 202012.36M6.57M113.56%
Dec 31, 20195.79M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Hyperion DeFi1.40M
ImageneBio800.00K
Mereo BioPharma Group500.00K
Clene197.00K
Serina Therapeutics130.00K
Revenue Rankings